WFDC10A
Basic information
Region (hg38): 20:45629739-45631196
Previous symbols: [ "C20orf146" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WFDC10A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 8 | 1 | 0 |
Variants in WFDC10A
This is a list of pathogenic ClinVar variants found in the WFDC10A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-45629826-A-G | Inborn genetic diseases | Likely benign (Aug 16, 2021) | ||
20-45629868-G-T | not specified | Uncertain significance (Mar 24, 2023) | ||
20-45629886-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
20-45629891-G-C | not specified | Uncertain significance (Dec 28, 2022) | ||
20-45629894-G-C | not specified | Uncertain significance (Jan 06, 2023) | ||
20-45630895-A-C | not specified | Uncertain significance (Mar 31, 2024) | ||
20-45630897-T-A | not specified | Uncertain significance (Jan 23, 2024) | ||
20-45630933-A-T | not specified | Uncertain significance (Feb 23, 2023) | ||
20-45630963-C-A | not specified | Uncertain significance (Mar 20, 2024) | ||
20-45630971-A-G | not specified | Uncertain significance (Nov 08, 2022) | ||
20-45630977-T-C | not specified | Uncertain significance (Nov 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WFDC10A | protein_coding | protein_coding | ENST00000372643 | 2 | 1671 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0144 | 0.462 | 115274 | 0 | 1 | 115275 | 0.00000434 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0496 | 40 | 39.1 | 1.02 | 0.00000191 | 500 |
Missense in Polyphen | 4 | 7.9213 | 0.50497 | 100 | ||
Synonymous | -0.909 | 20 | 15.5 | 1.29 | 6.69e-7 | 155 |
Loss of Function | -0.795 | 2 | 1.10 | 1.82 | 4.64e-8 | 14 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000940 | 0.00000940 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.602
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 62.74
Haploinsufficiency Scores
- pHI
- 0.0620
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.384
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.445
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of endopeptidase activity
- Cellular component
- extracellular region
- Molecular function
- serine-type endopeptidase inhibitor activity